Galectin Therapeutics GALT
NASDAQ GALT
$3.85 -0.07 (-1.66%)
As of: Sep 30, 2026 · 10:01 AM EDT

Galectin Therapeutics (GALT) Operating Expenses (2010 - 2026)

Updated

Galectin Therapeutics (GALT) posted Operating Expenses of $3.98 million for Q2 2026, down 13.9% from $4.63 million a year earlier and down 2.3% from the prior quarter.

Analysis

Galectin Therapeutics (GALT) Operating Expenses (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Galectin Therapeutics was $15.62 million, down 54.1% year-over-year; for FY2025, it was $20.09 million, down 52.7% from FY2024.

  • Annual Operating Expenses shows a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
  • In prior years, Galectin Therapeutics' Operating Expenses was $42.43 million in FY2024 (+11.5%), $38.07 million in FY2023 (-0.7%), $38.35 million in FY2022 (+27.1%) and $30.18 million in FY2021 (+28.7%).
  • Quarterly Operating Expenses has run from a low of $3.37 million in Q4 2025 to a high of $12.43 million in Q4 2024 over five years.
  • On a year-over-year basis, Operating Expenses has declined in each of the last six quarters, with an average decline of 29.6% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q1 2022, with growth of 57.3%; the weakest was Q4 2025, with a decline of 72.9%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $4.08 million (Q1 2026), $3.37 million (Q4 2025) and $4.2 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Galectin Therapeutics 260.61 Mn 260.61 Mn - 3.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.98 Mn
Mar 31, 2026 4.08 Mn
Dec 31, 2025 3.37 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 4.63 Mn
Mar 31, 2025 7.90 Mn
Dec 31, 2024 12.43 Mn
Sep 30, 2024 9.07 Mn
Jun 30, 2024 11.29 Mn
Mar 31, 2024 9.65 Mn
Dec 31, 2023 9.56 Mn
Sep 30, 2023 9.17 Mn
Jun 30, 2023 9.00 Mn
Mar 31, 2023 10.34 Mn
Dec 31, 2022 10.63 Mn
Sep 30, 2022 8.12 Mn
Jun 30, 2022 9.66 Mn
Mar 31, 2022 9.94 Mn
Dec 31, 2021 7.43 Mn
Sep 30, 2021 8.24 Mn
API Access

Galectin Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=GALT&period=max&api_key=YOUR_API_KEY